972 filings
Page 4 of 49
4
po55zag 4n8jg8
16 Mar 23
Acer Therapeutics / John Michael Klopp ownership change
4:43pm
4
metzpc4qpfro
16 Mar 23
Acer Therapeutics / Donald Joseph ownership change
4:41pm
4
n6vje6dl l05bbmxhz
16 Mar 23
Acer Therapeutics / Tanya Hayden ownership change
4:39pm
4
csq64tj
16 Mar 23
Acer Therapeutics / MICHELLE RENEE GRIFFIN ownership change
4:37pm
4
hcvtoy09c7vvwg839v
16 Mar 23
Acer Therapeutics / JOHN MICHAEL DUNN ownership change
4:35pm
4
vdi5k75t
16 Mar 23
Acer Therapeutics / Jefferson E Davis ownership change
4:32pm
4
8vwgpmdmk
16 Mar 23
Acer Therapeutics / STEVE ASELAGE ownership change
4:30pm
4
9lsa5qqs73yvpyu8tm
16 Mar 23
Acer Therapeutics / Jason Amello ownership change
4:21pm
8-K
rzlcsuj 5y
15 Mar 23
Other Events
9:00am
SC 13G/A
4qczsbdz 8a9t9zk7fw
14 Feb 23
Acer Therapeutics / Nantahala Capital Management ownership change
4:56pm
8-K
g7ylxw8 jpcu1v
13 Feb 23
Topline trial results expected mid-March 2023
9:00am
424B2
pslbdx d5
7 Feb 23
Prospectus for primary offering
4:08pm
8-K
nyv6pjz93n0r49
7 Feb 23
Other Events
4:01pm
8-K
wv5cg6bcm15dp bl9
1 Feb 23
Regulation FD Disclosure
4:03pm
8-K
q9292tk5sxhpyn nfzw
31 Jan 23
Entry into a Material Definitive Agreement
9:25am
8-K
yojhec bc
9 Jan 23
Acer Therapeutics Highlights Key 2022 Achievements and Pipeline Advancements, and Provides Anticipated 2023 Milestones
9:00am
8-K
le2hhqcs xulcs5be
5 Jan 23
Regulation FD Disclosure
9:00am
8-K
p6r9kon3n8 5p5o7yywh
3 Jan 23
Entry into a Material Definitive Agreement
9:00am
8-K
ogi8b
29 Dec 22
Other Events
9:00am
8-K
17t1qziv3r3206sfm79t
27 Dec 22
New FDA-approved formulation for patients living with urea cycle disorders
8:33am